Fabio Grassi

Company: MV Biotherapeutics

Job title: Founder & Chief Executive Officer

Seminars:

Reprogramming the Microbiome in Cancer Immunotherapy 2:00 pm

Outlining the adaptive modulation of the microbiota in dysbiosis by apyrase-mediated secretory IgA amplification Exploring gut ecosystem proficiency in cancer immunotherapy by oral administration of apyraseRead more

day: Day Two Track C PM